Curated News
By: NewsRamp Editorial Staff
August 21, 2025

Mileutis Wins Prestigious AgTech Award for Antibiotic-Free Dairy Solution

Reddit Discuss on LinkedIn View History of this news story on GitHub
Original Source

TLDR

  • Mileutis' IMILAC gives dairy farmers a competitive edge by boosting milk yield and quality while eliminating antibiotic costs and milk waste.
  • IMILAC works by using milk-derived peptides to activate cows' natural immune defenses, preventing and treating mastitis without antibiotics through proven clinical trials.
  • IMILAC promotes global health by reducing antibiotic use, combating antimicrobial resistance, and supporting sustainable farming practices for a healthier planet.
  • Mileutis won the 2025 AgTech Breakthrough Award for IMILAC, a natural therapy that enhances cow immunity and milk production without antibiotics.

Impact - Why it Matters

This development matters significantly because it addresses the critical global issue of antimicrobial resistance while transforming dairy farming practices. As antibiotic overuse in agriculture contributes to the rise of drug-resistant superbugs that threaten human health, solutions like IMILAC offer a sustainable alternative that protects both animal welfare and public health. For consumers, this means safer dairy products without antibiotic residues, while farmers benefit from improved herd health, increased milk production, and reduced waste. The technology represents a crucial step toward more sustainable food production systems that balance productivity with environmental and health considerations.

Summary

Mileutis, a pioneering ag-biotech company, has achieved a significant milestone as its innovative product IMILAC was honored with the prestigious 2025 AgTech Breakthrough Award in the Dairy Productivity Solution category. This recognition highlights the company's breakthrough approach to animal health through antibiotic-free biologic therapies that transform dairy farming practices. The award from AgTech Breakthrough celebrates solutions that drive sustainable innovation in agriculture, positioning Mileutis at the forefront of this transformative movement.

IMILAC represents a revolutionary advancement in dairy cow health management—a milk-derived, residue-free therapy that strengthens cows' natural immune systems to prevent and treat mastitis without antibiotics. Through extensive clinical trials, the product has demonstrated remarkable results: improved milk yield, enhanced milk quality, and reduced waste from discarded milk. As CEO David Javier Iscovich emphasized, this achievement underscores the power of science-driven innovation that simultaneously addresses antimicrobial resistance while supporting farmer productivity and animal welfare.

The development of IMILAC builds upon more than a decade of research into naturally occurring milk peptides and their immune-activating properties, as explained by Chief Scientific Officer Dr. Jose Iscovich. By replacing conventional antibiotic and hormone treatments with this natural solution, Mileutis is tackling one of the most pressing challenges in modern agriculture while promoting sustainable farming practices. This breakthrough not only benefits dairy farmers through increased efficiency and reduced medication costs but also contributes to global health by combating antimicrobial resistance and ensuring safer dairy products for consumers.

Source Statement

This curated news summary relied on content disributed by citybiz. Read the original source here, Mileutis Wins Prestigious AgTech Award for Antibiotic-Free Dairy Solution

blockchain registration record for this content.